These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1469903)

  • 21. Chemoprevention of cancer.
    Tsao AS; Kim ES; Hong WK
    CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.
    Papadimitrakopoulou VA; Shin DM; Hong WK
    Cancer Metastasis Rev; 1996 Mar; 15(1):53-76. PubMed ID: 8842479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials.
    Copper MP; Braakhuis BJ; de Vries N; van Dongen GA; Nauta JJ; Snow GB
    Cancer; 1993 Feb; 71(3):825-30. PubMed ID: 8431864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention of aerodigestive tract cancers.
    Kim ES; Hong WK; Khuri FR
    Annu Rev Med; 2002; 53():223-43. PubMed ID: 11818472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in chemoprevention of cancer.
    Hong WK; Sporn MB
    Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
    Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
    Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
    J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention strategies: the relevance of premalignant and malignant lesions of the upper aerodigestive tract.
    Schantz SP
    J Cell Biochem Suppl; 1993; 17F():18-26. PubMed ID: 8412190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in upper aerodigestive tract tumorigenesis: a review.
    Shin DM; Hittelman WN; Hong WK
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):697-709. PubMed ID: 7881344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate biomarkers for application as intermediate end points of lung carcinogenesis.
    Mulshine JL; Linnoila RI; Treston AM; Scott FM; Quinn K; Avis I; Shaw GL; Jensen SM; Brown P; Birrer MJ
    J Cell Biochem Suppl; 1992; 16G():183-6. PubMed ID: 1469899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer chemoprevention.
    Lippman SM; Benner SE; Hong WK
    J Clin Oncol; 1994 Apr; 12(4):851-73. PubMed ID: 8151328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer.
    Papadimitrakopoulou VA; Hong WK
    Int J Cancer; 2000 Dec; 88(6):852-5. PubMed ID: 11093804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoids: application in premalignant lesions and oral cancer.
    Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
    Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of aerodigestive cancer.
    Berwick M; Schantz S
    Cancer Metastasis Rev; 1997; 16(3-4):329-47. PubMed ID: 9433643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premalignant lesions of the upper aerodigestive tract: biomarkers of genetic alterations, proliferation, and differentiation.
    Crissman JD; Visscher DW; Sarkar FH
    J Cell Biochem Suppl; 1993; 17F():192-8. PubMed ID: 8412193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermediate biomarkers of precancer and their application in chemoprevention.
    Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of premalignant lesions of the upper aerodigestive tract. Workshop, February 10-14, 1993, Amelia Island, Florida. Proceedings.
    J Cell Biochem Suppl; 1993; 17F():1-300. PubMed ID: 8412182
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemoprevention of lung cancer--from biology to clinical reality.
    Winterhalder RC; Hirsch FR; Kotantoulas GK; Franklin WA; Bunn PA
    Ann Oncol; 2004 Feb; 15(2):185-96. PubMed ID: 14760107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung epithelial proliferation: a biomarker for chemoprevention trials?
    Szabo E
    J Natl Cancer Inst; 2001 Jul; 93(14):1042-3. PubMed ID: 11459858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.